SGRY
Surgery Partners, Inc.
Overview
Surgery Partners operates a national network of ambulatory surgery centers, surgical hospitals, and physician practices across 30 states, generating approximately $3.2 billion in annual revenue from outpatient surgical procedures.
Surgery Partners, Inc is a Healthcare company operating in Medical Care Facilities with a $1.90B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0520 Q&A exchanges
- Q4 FY2025Earnings2026-03-03
- Q3 FY2025Earnings2025-11-1029 Q&A exchanges
- Q2 FY2025Earnings2025-08-0520 Q&A exchanges
- Q1 FY2025Earnings2025-05-1217 Q&A exchanges
- Q4 FY2024Earnings2025-03-0326 Q&A exchanges
- Q3 FY2024Earnings2024-11-1231 Q&A exchanges
- Q2 FY2024Earnings2024-08-0624 Q&A exchanges
- Q1 FY2024Earnings2024-05-0725 Q&A exchanges
- Q4 FY2023Earnings2024-02-2625 Q&A exchanges
- Q3 FY2023Earnings2023-11-0727 Q&A exchanges
- Q2 FY2023Earnings2023-08-0118 Q&A exchanges
- Q1 FY2023Earnings2023-05-0116 Q&A exchanges
- Q4 FY2022Earnings2023-03-0130 Q&A exchanges
- Q3 FY2022Earnings2022-11-129 Q&A exchanges
- Q2 FY2022Earnings2022-08-0218 Q&A exchanges
- Q1 FY2022Earnings2022-05-0323 Q&A exchanges
- Q4 FY2021Earnings2022-03-0131 Q&A exchanges
- Q3 FY2021Earnings2021-11-0225 Q&A exchanges
- Q2 FY2021Earnings2021-08-0823 Q&A exchanges
- Q1 FY2021Earnings2021-05-0822 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.03—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.03 | — | — | — | — | EODHD |
Source: EODHD. SGRY reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks SGRY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.78 | $3.19 | +18.6% | +8.6% | +6.2% |
| Q4 FY2026 | $3.90 | $3.27 | +19.4% | +6.2% | +8.7% |
| Q3 FY2026 | $3.99 | $3.47 | +15.1% | +7.0% | +6.7% |
| Q2 FY2026 | $4.28 | $3.42 | +25.0% | +5.7% | +8.2% |
| Q1 FY2025 | $4.10 | $3.49 | +17.5% | +0.3% | -2.1% |
| Q4 FY2025 | $4.00 | $3.49 | +14.6% | +2.3% | +2.8% |
| Q3 FY2025 | $3.88 | $3.35 | +15.9% | -2.8% | -5.0% |
| Q2 FY2025 | $4.10 | $3.54 | +15.9% | +5.9% | +3.8% |
| Q1 FY2024 | $4.28 | $3.51 | +21.8% | +3.9% | +3.3% |
| Q4 FY2024 | $4.43 | $3.44 | +28.7% | -2.5% | -0.6% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Jason Eric EvansCEO3 mono recorded callsCurrentSample
CEO since 2026 • 1/2 beats (50%) • guidance suspended Q1 FY2026
- David T DohertyCFO1 yr 3 mo5 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- William Trenton WebbPresident1 yr 3 mono recorded callsCurrentSample
PRESIDENT since 2025 • 3/4 beats (75%) • guidance suspended Q1 FY2026
- Harrison R BanePresident1 yr 3 mono recorded callsCurrentSample
PRESIDENT since 2025 • 2/4 beats (50%) • last guidance raise Q3 FY2026
- Justin Robert OppenheimerCOO5 mono recorded callsCurrentSample
COO since 2026 • 1/2 beats (50%) • last guidance raise Q3 FY2026
- Marissa BrittenhamChief Strategy Officer1 yr 3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SGRY.
$ curl https://api.spokenalpha.com/v1/companies/SGRYFAQ
Frequently asked about SGRY
Where can I find Surgery Partners, Inc.'s (SGRY) earnings call transcripts?
Spoken Alpha indexes SGRY's earnings call transcripts at https://spokenalpha.com/companies/SGRY. Each call links to attributed speakers and parsed analyst Q&A. Surgery Partners, Inc.'s own investor relations page is at https://ir.surgerypartners.com/.
When was Surgery Partners, Inc.'s most recent earnings call?
Surgery Partners, Inc. (SGRY) held its most recent earnings call on 2026-05-05, covering fiscal Q1 2026.
What sector is SGRY in?
Surgery Partners, Inc. (SGRY) operates in the Healthcare sector (Medical Care Facilities industry).